Jeito Capital

News

Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.

News

A media report suggests there is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.